Diacol

Quick links to important sections

Diacol

Selected form

Treatment option: Cough

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diacol

What is Diacol? Definition and Overview

Property Description
Active ingredient Dextromethorphan Hydrobromide
Form Oral Solution, Syrup, Tablets, Lozenges
Pharmacological class Antitussive (Cough Suppressant)
Common use Symptomatic relief of persistent cough
Origin Synthetic (Morphinan derivative)

What is Diacol and What Type of Medicine is It?

Diacol is a pharmaceutical preparation primarily classified as an antitussive or cough suppressant, intended to manage the cough reflex. Its single active ingredient is Dextromethorphan Hydrobromide. This compound is a synthetic morphinan derivative that is clinically recognized for its central action on the nervous system. Dextromethorphan is designated as non-opioid in its therapeutic use at antitussive doses. This structural differentiation confirms that the preparation is designed for symptomatic cough management and is not utilized for pain relief.


Composition and Pharmaceutical Forms of Diacol

The preparation’s efficacy is centered on Dextromethorphan Hydrobromide, the essential chemical entity responsible for suppressing cough signals. Diacol is intended for oral administration and is commonly available in several convenient dosage forms, including an oral solution or syrup base, as well as solid forms such as tablets or lozenges. The composition typically involves the active ingredient combined with an appropriate pharmaceutical vehicle, such as an aqueous or syrup base. The pharmacological class is recognized for its action on the central nervous system to reduce coughing frequency.


General Purpose: How Diacol Helps with Cough

The general purpose of Diacol is to provide symptomatic relief by specifically reducing the frequency and intensity of persistent, unproductive coughing. It achieves this by acting directly on the brain’s cough center in the medulla, effectively depressing the nerve signals that involuntarily trigger a cough. Dextromethorphan is used as a symptomatic treatment for cough. This medicine is typically sought when a cough is irritating or disruptive, offering comfort by muting the reflex itself.

Regulatory References

  1. U.S. National Library of Medicine
  2. MedlinePlus
  3. WHO Model List of Essential Medicines
  4. WHO

What side effects are possible with Diacol?

Possible Side Effects and Safety Information

The official safety profile of Diacol (Dextromethorphan Hydrobromide) is characterized by classifying possible adverse effects primarily by frequency and the body system affected, according to regulatory documents.

Adverse Reaction Categories

Adverse effects listed in official product information mainly affect the Nervous System and the Gastrointestinal System. Many reactions are categorized as Rare in regulatory texts. These may include dizziness, drowsiness, nausea, and vomiting.

Classification Examples of Officially Documented Effects
Rare Dizziness, Nausea, Drowsiness, Allergic skin reactions
Frequency Not Known Agitation, Hallucinations, Serotonin Syndrome

Serious Safety Constraints

The most serious safety consideration documented by regulatory agencies relates to drug interactions. Diacol is absolutely contraindicated for use during or within 14 days of discontinuing therapy with Monoamine Oxidase Inhibitors (MAOIs), due to the high risk of precipitating Serotonin Syndrome.

Population-Specific Notes

Safety constraints also apply to certain patient groups. Official documents advise that older adults may be more susceptible to central nervous system effects, and caution is needed for individuals with hepatic impairment. Use in children under certain ages is often restricted or not recommended as stated in government-approved labeling.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Diacol (Dextromethorphan Hydrobromide) defines overdose based on documented systemic toxicity and mandatory emergency action. The symptoms listed in regulatory documents affect the central nervous system (CNS), cardiovascular, and respiratory systems.

Feature Official Regulatory Statements
Documented Manifestations Signs include confusion, agitation, visual hallucinations, ataxia (unsteady walking), nystagmus, seizures, tachycardia (rapid heartbeat), hypertension, hyperthermia, and severe gastrointestinal symptoms like vomiting.
Severe Outcomes Potentially life-threatening complications explicitly listed are Serotonin Syndrome, profound respiratory depression, and coma (loss of consciousness). Respiratory difficulties are noted as particularly severe in young children.
Emergency Actions Management is defined as symptomatic and supportive. Interventions may include administering activated charcoal (if recent ingestion), using Benzodiazepines for agitation or seizures, and considering Naloxone to manage respiratory or CNS depression.

When Immediate Medical Help is Required: Official guidance mandates that an individual must seek immediate medical attention or contact a Poison Control Center right away if overdose is suspected. This is required upon the presentation of any severe sign, especially breathing difficulties, seizures, loss of consciousness, or signs indicative of Serotonin Syndrome. Co-ingestion with other serotonergic medicines is cited as a factor that may increase the risk of toxic effects.

Therapeutic Uses of Diacol

What Diacol Treats: Main Uses and Benefits

The primary therapeutic role of Diacol (Dextromethorphan Hydrobromide) is to provide symptomatic relief by assisting with the management of the cough reflex. This medication is commonly used when short-term symptomatic assistance is needed for symptoms that create noticeable physiological strain and interfere with daily comfort.

It is relevant in clinical settings that involve acute symptom patterns, helping to address symptom clusters that may appear suddenly and intensify temporarily, such as those associated with the common cold, influenza, and minor upper respiratory tract infections. Diacol is commonly used to help manage the symptom clusters related to irritative states, specifically addressing the unproductive (dry) cough.

This antitussive support generally applies in contexts where additional symptomatic support is needed to ease the force and frequency of coughing. The medication supports the patient during difficult episodes by easing the distress caused by the persistent urge to cough. This symptomatic relief helps maintain a sense of stability when cough symptoms become more noticeable and supports patients during episodes of heightened discomfort, particularly those that interfere with rest and sleep.


Quick Fact: Symptomatic Support for Irritating Cough

Diacol is commonly used to help manage the symptom clusters related to irritative states, providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Official Population Eligibility for Diacol

Eligibility for using Diacol (Dextromethorphan Hydrobromide) is strictly defined by regulatory documents, which establish clear restrictions based on age, concurrent medication use, and pre-existing health conditions.


Eligibility Status Summary

Category Official Regulatory Statement
Eligible for Standard Use Adults and adolescents 12 years of age and older
Absolute Contraindication Patients taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping MAOI therapy.
Age Contraindication Children under 2 years of age.
Use Not Recommended Children under 4 years of age and patients with a chronic or productive cough (cough with excessive mucus).

Specific Population Restrictions

Use is restricted and caution is required for patients with moderate to severe hepatic (liver) impairment and those with severe renal (kidney) impairment. For pregnancy and lactation, use is conditional; regulatory agencies classify it as restricted, recommending professional consultation. The medicine is not intended for the management of chronic cough associated with conditions like asthma or emphysema.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation identifies several key drug and substance categories with which Diacol has documented interactions, necessitating specific constraints on co-administration.

Documented Interaction Categories and Constraints

Interaction Category Specific Constraint or Requirement
Monoamine Oxidase Inhibitors (MAOIs) Concomitant use is restricted due to the serious, documented risk of an apparent serotonin syndrome.
Terfenadine and Diphenhydramine Co-administration is not recommended as documented life-threatening interactions have been reported.
CNS Depressant Drugs (e.g., alcohol, sedatives, tranquilizers) Avoid alcoholic beverages. Caution is required when combining with sedatives or tranquilizers due to the potential for additive CNS depressant effects.
Selective Serotonin Reuptake Inhibitors (SSRIs) Use with caution and monitoring is required due to the documented risk of an apparent serotonin syndrome.
Other Topical Acne Products Co-administration may increase the risk of skin dryness or irritation; use of only one topical product may be required.

These official regulatory statements define the product’s interaction profile based on pharmacokinetic or pharmacodynamic risks. The strongest constraints mandate avoiding specific combinations, such as with MAOIs, to mitigate the risk of serious adverse effects. Other documented interactions require caution and medical consultation to manage potential additive effects, such as with CNS depressants, or local adverse reactions, as noted with other topical agents. Additionally, usage notes indicate very limited use in atopic children due to the ability to trigger a documented histamine release.

Mechanism of Action

Diacol is a bowel evacuant that contains sodium phosphate as the active component. Its mechanism of action is primarily classified as osmotic. The drug is administered orally, with the sodium and phosphate ions remaining largely within the gastrointestinal lumen. Due to the high concentration of these non-absorbable ions, a hypertonic gradient is established within the bowel. This osmotic effect drives a substantial net flux of water from the surrounding plasma and interstitial fluid into the intestinal lumen, a process governed by fundamental principles of water potential and membrane permeability.

The resulting increase in luminal fluid volume elevates intraluminal pressure and causes rapid distention of the colon wall. This physical distention acts as a powerful mechanical stimulus, activating propulsive motility and facilitating a downstream cascade of events leading to high-volume, liquid colonic contents and subsequent rapid systemic elimination of the luminal contents.

Dosage and Administration Information

Diacol (Dextromethorphan Hydrobromide) is administered exclusively via the oral route. It is available in immediate-release (IR) forms, such as syrups, tablets, and lozenges, as well as extended-release (ER) suspensions.

Feature Official Usage Guideline
Dosing Schedule (≥ 12 yrs) IR products: 10 mg to 20 mg every 4 hours, or 30 mg every 6 to 8 hours. The maximum dose must not exceed 120 mg in a 24-hour period.
Duration Limit Use is intended for the short-term management of symptoms and should be discontinued if use exceeds 7 days.
Food Relation The medication can be taken with or without food.

Preparation and Administration: Liquid forms, especially suspensions, require the bottle to be shaken well prior to use. Measuring devices must be calibrated (dose cup, syringe, or spoon) and should not be substituted with common household spoons to ensure accurate administration. Tablets and capsules are generally instructed to be swallowed whole.

Population Rules: The standard dosing schedule applies to individuals 12 years and older. Specific, lower doses are documented for children aged 6 to 11 years, with a reduced maximum daily limit of 60 mg for IR products. Many immediate-release labels carry an explicit instruction to “Do Not Use” in children under 6 years. In the event of a missed dose, the common practice is to take it when remembered, but not doubled up if the next scheduled dose is near. This information describes the standardized, controlled administration of Diacol.

Recent Clinical Evidence

Research evidence / Overview of Studies for Diacol (Dextromethorphan Hydrobromide)

This section provides an overview of the clinical research conducted on Diacol's active ingredient, focusing on the types of studies performed, what was measured, and where scientific uncertainty remains. This information is descriptive and does not constitute medical advice or treatment recommendations.

Evidence for Acute Cough Associated with the Common Cold

Research exploring the question of Diacol's role in acute cough, such as the persistent cough associated with the common cold, primarily involves short-term Randomized Controlled Trials (RCTs) and scientific literature reviews. These trials generally focused on research exploring how symptoms change over time during a temporary illness.

Studies monitored various outcomes related to the cough symptom. Researchers examined objective measurements of cough frequency and also applied studies examining patient-reported experiences, specifically looking at changes in subjective cough severity and patient reports related to sleep quality and rest. In studies of adults, available evidence is mixed. Some trials reported patterns where objective cough count measurements were evaluated for differences between the drug group and the placebo group. However, findings were mixed when evaluating subjective measures of symptom change; in many trials, the reported symptomatic change was similar between the drug group and the placebo group. This observation indicates that the measured physiological effects do not consistently align with the patient-reported experience.

Study Focus on Children and Other Special Populations

The research exploring short-term symptom changes was evaluated in specific age groups, including children aged 6 to 11 years with cough due to the common cold. The evidence quality varies across studies, with several independent reviews indicating that in most trials involving children, the reported symptomatic outcomes were not found to be different from those children who received a placebo. Evidence is limited in infants and toddlers, and research is insufficient to characterize the effects in children under six years of age.

Current Gaps and Areas of Research Uncertainty

A key limitation in this area is the inherent difficulty in separating findings from the placebo response rate, which is frequently reported in acute cough studies. Furthermore, the recurring inconsistency between objective cough counts and patient-reported symptom change contributes to the overall uncertainty. Long-term outcomes are not characterized, as the research focuses on short-term use. More high-quality research is ongoing, and study results reflect the specific conditions and populations under which they were conducted.

Key Studies & References

  1. Over-the-counter cough medicines for acute cough in adults (Systematic Review)
  2. Cough (acute): antimicrobial prescribing - NICE guideline [NG120] (Used for context on use in children/infants)
  3. Dextromethorphan Monograph (NIH DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Diacol (FAQ)


Q: How long does it usually take to notice an effect after starting Diacol?

The therapeutic effect of Diacol is generally observed shortly after it is taken. Official product information describes the active ingredient as being rapidly absorbed following oral administration. This description is consistent with the drug being rapidly available to act on the central nervous system.


Q: Can Diacol cause weight gain or weight loss?

According to the official product information and adverse event reports, changes in body weight are not listed among the commonly or rarely documented side effects of Diacol. The full product labeling should be reviewed by a healthcare provider if a patient experiences unexpected weight changes.


Q: Is it necessary to avoid alcohol completely while taking Diacol?

Regulatory documents state that alcoholic beverages must be avoided when taking Diacol. This constraint is in place because combining Diacol with alcohol may lead to an increased potential for additive depressant effects on the Central Nervous System.


Q: Is it normal to feel slightly dizzy when first starting Diacol?

Dizziness is documented in official safety information, where it is classified as a rare adverse effect. The product label does not specifically address the initial experience of these effects, but the classification of dizziness as 'rare' is documented in official safety information.


Q: Does taking Diacol mean I have to change my diet?

The medication is officially stated to be administered with or without food. There are generally no broad dietary restrictions or changes required in regulatory product information related to taking Diacol.


Q: Does Diacol interact with common foods or specific beverages?

Regulatory documents specifically constrain the use of alcoholic beverages while taking Diacol. However, the official interaction profile does not list specific interactions with common foods or non-alcoholic beverages.


Q: How often do the clinical trials show Diacol provides a significant benefit?

Clinical research reports mixed findings regarding the consistency of significant benefit in trials, with inconsistency observed between objective measurements (like cough count) and the relief reported by patients themselves. Reports from some pediatric studies indicated no significant difference in symptomatic change compared to the placebo group.


Q: Does Diacol affect liver function or kidney function?

Official warnings and precautions list restrictions and caution for use in patients with pre-existing moderate to severe hepatic (liver) impairment and severe renal (kidney) impairment. The necessity of caution for these groups underscores the importance of reviewing eligibility with a healthcare professional.


Q: Can Diacol be used by children, and is it approved for pediatric use?

Diacol has defined dosing schedules for adolescents and adults, as well as specific, lower doses for children aged 6 to 11 years. However, use is generally restricted or not recommended for children under 6 years of age in official labeling.


Q: Can taking Diacol affect a person's mood or emotional state?

Adverse effects documented in regulatory texts include Central Nervous System effects such as agitation and hallucinations. While the frequency of these particular effects is described as not known, they represent documented impacts on a person’s mental or emotional state.


Q: If I miss a dose of Diacol, what is the general guidance?

Regulatory guidance advises that a missed dose should be taken when remembered. The official guidance states that the dose should not be doubled if the time for the next scheduled dose is near.


Q: How quickly does Diacol leave the body after the last dose?

Regulatory documents contain pharmacokinetic data, including the elimination half-life. This information characterizes the rate at which the active ingredient is processed and removed from the body.


Q: What information is legally required to be included in the patient leaflet for Diacol?

Regulatory agencies mandate that patient leaflets must contain essential factual information for safe use. This includes details regarding dosage, contraindications (reasons not to use), side effects, and drug interactions as defined in the official product label.


Q: Are allergic reactions to Diacol common?

Official product information lists allergic skin reactions as a rare adverse effect. The frequency of more severe allergic responses is documented within the drug’s full safety profile.


Q: Is Diacol known to cause fatigue or sleepiness?

Drowsiness is listed as a rare adverse effect in official documentation. However, fatigue is not typically listed as a distinct, documented adverse reaction in the safety profile.


Q: How long can I expect to be on Diacol treatment?

Treatment with Diacol is constrained for short-term management of symptoms. Official regulations indicate that the use is intended to be discontinued if it exceeds seven days per episode.


Q: Does Diacol interact with birth control pills?

The regulatory interaction profile addresses major drug categories, such as SSRIs and MAOIs. Specific interaction studies or warnings regarding oral contraceptives are not typically documented in the main product label.


Q: Are there any mandatory checks or tests needed before starting Diacol?

Official documents do not typically mandate specific laboratory tests before starting use. Patients with pre-existing conditions, particularly severe hepatic or renal impairment, are noted in regulatory information as requiring review with a healthcare professional to determine appropriateness of use.


Q: Is Diacol a controlled substance?

Diacol's active ingredient, Dextromethorphan Hydrobromide, is defined by regulatory scheduling documents as not a controlled substance at its approved therapeutic antitussive doses in most major jurisdictions.


Q: Can Diacol be used for purposes other than the main condition it treats?

Official regulatory approval is granted only for the treatment of symptomatic relief of persistent cough. Use for any other purpose is not addressed in regulatory indications.


Q: Can Diacol be taken with high-dose vitamin supplements?

The regulatory interaction profile addresses specific drug and herbal categories (such as St. John's Wort). However, it does not contain a general statement regarding high-dose vitamin supplements.


Q: Does Diacol affect the results of common blood tests?

Regulatory documentation lists information on known potential interference with certain laboratory testing. For example, it may cause the possibility of false positive results for specific drugs on certain screening tests.


Q: Are there different forms of Diacol available (e.g., tablet, liquid)?

Yes, the product is manufactured in several forms for oral administration. These include an oral solution or syrup base, as well as solid forms such as tables or lozenges.


Q: Why is regular monitoring sometimes recommended while taking Diacol?

Monitoring or increased caution is recommended for specific patient groups due to the potential for central nervous system effects. This applies particularly to older adults and patients with pre-existing hepatic or renal impairment.


Q: Why is the mechanism of action of Diacol relevant to its side effect profile?

The mechanism of action involves a central action, meaning it works on the brain’s cough center. This central activity is directly linked to the most frequent documented side effects, which primarily affect the Nervous System (such as dizziness and drowsiness).


Q: Do women and men experience side effects from Diacol differently?

Official regulatory documents generally report safety data aggregated across the entire study population. They typically do not distinguish side effect frequency by sex unless a specific risk or difference has been clearly identified in clinical trials.


Q: Where can I find the official regulatory documents for Diacol?

Official documentation, such as the full product label (DailyMed) or Summary of Product Characteristics (SmPC), is publicly accessible via the respective governmental drug regulatory authority websites (e.g., FDA, EMA, Health Canada).


Q: What happens if I stop taking Diacol suddenly?

Regulatory documentation does not report a specific withdrawal syndrome or requirement for tapering the dose. This indicates the drug is generally not associated with dependency requiring specific cessation protocols at approved therapeutic doses.

How should Diacol be stored and disposed of?

How to Store and Dispose of Diacol?

The storage and disposal of Diacol (Dextromethorphan Hydrobromide) must comply with official regulatory guidelines to maintain product stability and ensure public safety.


Storage Conditions

  • Temperature: Store at controlled room temperature, typically between 20 C and 25 C. Excessive heat must be avoided.
  • Protection: The medicine must be kept in the original container with the cap tightly closed and protected from moisture. Liquid forms must avoid freezing.
  • Child Safety: All forms of Diacol must be kept out of the sight and reach of children.

Disposal Requirements

  • Disposal: Unused or expired medication should be returned to a pharmacist or a designated drug take-back program.
  • Environmental Constraint: The product must not be disposed of via wastewater or regular household trash, in accordance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diacol found in:

A-Z Index: